Market Overview

Benzinga's Volume Movers

Related BAX
Benzinga's Top Upgrades, Downgrades For January 3, 2018
JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans
FDA OKs Baxter's ready-to-use formulation of anticoagulant bivalirudin (Seeking Alpha)
Related CLVS
Credit Suisse Adjusts Its Top Picks List In A Record-Breaking Market
Benzinga's Top Upgrades, Downgrades For October 23, 2017
U.S. Biotech/Pharma Sector Daily Observations Letter: January 22, 2018 (Seeking Alpha)

Baxter International (NYSE: BAX) shares rose 4.88% to $73.50. The volume of Baxter International shares traded was 740% higher than normal. Baxter announced its plans to split itself into two companies.

Clovis Oncology (NASDAQ: CLVS) shares climbed 3.10% to $79.90. The volume of Clovis Oncology shares traded was 457% higher than normal. Clovis Oncology reported positive Phase 1 trial results for NSCLC treatment.

Lululemon Athletica (NASDAQ: LULU) surged 7.95% to $52.06. The volume of Lululemon shares traded 374% higher than normal. Lululemon reported better-than-expected fourth-quarter earnings and issued a downbeat first-quarter outlook.

Orthofix International NV (NASDAQ: OFIX) shares moved up 12.09% to $29.75. The volume of Orthofix International shares traded was 254% higher than normal. Orthofix reported a Q4 loss of $0.60 per share on revenue of $106.10 million.

Posted-In: volume moversNews Intraday Update Markets Movers


Related Articles (BAX + CLVS)

View Comments and Join the Discussion!